U.S. markets closed
  • S&P 500

    4,567.00
    -88.27 (-1.90%)
     
  • Dow 30

    34,483.72
    -652.22 (-1.86%)
     
  • Nasdaq

    15,537.69
    -245.14 (-1.55%)
     
  • Russell 2000

    2,198.91
    -43.07 (-1.92%)
     
  • Crude Oil

    67.03
    +0.85 (+1.28%)
     
  • Gold

    1,776.50
    0.00 (0.00%)
     
  • Silver

    22.79
    +0.03 (+0.11%)
     
  • EUR/USD

    1.1340
    +0.0047 (+0.42%)
     
  • 10-Yr Bond

    1.4430
    -0.0870 (-5.69%)
     
  • GBP/USD

    1.3305
    -0.0007 (-0.05%)
     
  • USD/JPY

    113.2870
    -0.3210 (-0.28%)
     
  • BTC-USD

    57,353.25
    -739.87 (-1.27%)
     
  • CMC Crypto 200

    1,456.40
    +13.62 (+0.94%)
     
  • FTSE 100

    7,059.45
    -50.50 (-0.71%)
     
  • Nikkei 225

    27,821.76
    -462.16 (-1.63%)
     

10 Best Stocks Under $15 According to Billionaire Michael Price

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·10 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

In this article, we will take a look at the 10 best stocks under $15 according to Billionaire Michael Price. You can skip our detailed analysis of Price's history, investment philosophy, and hedge fund performance, and go directly to 5 Best Stocks Under $15 According to Billionaire Michael Price.

One of America's most successful value investors, Michael Price is the founder, chief executive officer and managing director of the New York-based hedge fund, MFP Investors. After earning his B.A in Business Administration from the University of Oklahoma, Michael Price began his investment career as a research assistant at Mutual Series, a fund under the management of acclaimed value investor Max Heine. After Heine's death in 1988, Michael Price bought the company and later sold it to Franklin Templeton Investments in 1996. In 1998, Price established his very own hedge fund, MFP Investors. Michael Price has a reputation as an activist investor, employing a strategy that focuses on stocks that are suppressed by the market and buying them at a significant discount to their actual values. Price examines such stocks through an extensive research process, and buys a stake within a company only if he finds that it possesses sufficient attributes to make good investment returns.

According to the recent 13F Filings, Michael Price's MFP Investors, as an investment fund, manages an estimated $910 million in its investment portfolio, with the Financial Services sector proving to be the heaviest, making up over 31.56% of the fund's total portfolio value.

10 Best Stocks Under $15 According to Billionaire Michael Price
10 Best Stocks Under $15 According to Billionaire Michael Price

Michael Price of MFP Investors

Our Methodology

With this background in mind, let us now look towards the 10 best stocks to under $15 according to Michael Price's MFP Investors. We made use of MFP Investors' 13F portfolio for the second quarter for this analysis. The following list will consist of the top stocks present in MFP Investors' portfolio that have a stock price below $15.

Why should we pay attention to Michael Price's stocks? Insider Monkey’s research was able to identify in advance a select group of hedge fund holdings that outperformed the S&P 500 ETFs by more than 86 percentage points since March 2017. Between March 2017 and July 2021 our monthly newsletter’s stock picks returned 186.1%, vs. 100.1% for the SPY. Our stock picks outperformed the market by 86 percentage points (see the details here). That’s why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to. You can subscribe to our free newsletter on our homepage to receive our stories in your inbox.

10 Best Stocks Under $15 According to Billionaire Michael Price.

10. Plains GP Holdings, L.P (NASDAQ:PAGP)

Price's Stake Value: $3.1 million

Percentage of Michael Price's 13F Portfolio: 0.34%

Number of Hedge Fund Holders: 15

Stock Price as of September 29: $10.79

Plains GP Holdings, L.P (NASDAQ:PABP) is a holding company that provides logistics services for crude oil and refined products, as well as operates energy infrastructure. The company has a market capitalization of $2.10 billion and is ranked tenth on the list of the 10 best stocks under $15 according to Michael Price. Plains GP Holdings, L.P. (NASDAQ:PAGP) shares have offered investors returns exceeding 45.63% over the course of the past 12 months.

According to the recent 13F Filings, Michael Price's MFP Investors holds over 260,518 shares of Plains GP Holdings, L.P (NASDAQ:PAGP), amounting to over $3.1 million in worth and accounting for 0.34% of the fund’s investment portfolio. At the end of the second quarter of 2021, 15 hedge funds in the database of Insider Monkey held stakes worth $77.4 million in Plains GP Holdings, L.P (NASDAQ:PAGP). The number of hedge funds with stakes in the company remained unchanged across the first and second quarters of 2021.

For the second quarter of 2021, Plains GP Holdings, L.P (NASDAQ:PAGP) reported earnings per share at $0.23, in line with market estimates. The company also reported revenues of $9.93 billion, surpassing estimates by $2.40 billion.

On July 13, Citi analyst Timm Schneider raised his price target on Plains GP Holdings, L.P (NASDAQ:PAGP) to $13 from $11 and kept a Buy rating on the shares.

9. Plains All American Pipeline, L.P. (NASDAQ:PAA)

Price’s Stake Value: $4.75 million

Percentage of Michael Price’s 13F Portfolio: 0.52%

Number of Hedge Fund Holders: 7

Stock Price as of September 29: $10.16

Plains All American Pipeline, L.P. (NASDAQ:PAA) is an oil and gas company based in Houston, Texas. Ranked ninth on the list of the 10 best stocks under $15 according to Michael Price, the company provides transportation and storage of crude oil and liquified petroleum gas with operations in US and Canada.

Michael Price's MFP Investors currently holds 418,581 shares of Plains All American Pipeline, L.P. (NASDAQ:PAA), worth $4.75 million and accounting for 0.52% of the fund's total portfolio value. At the end of the second quarter of 2021, 15 hedge funds in the database of Insider Monkey held stakes worth $65.9 million in Plains All American Pipeline, L.P (NASDAQ:PAA). The number of hedge funds with stakes in the company remained unchanged across the first and second quarters of 2021.

The company reported revenues of $9.93 billion in its earnings report for Q2 2021, which beat estimates by $3.20 billion. The EPS was reported to be $0.23, in-line with the estimates for the quarter.

On September 28, BofA analyst Chase Mulvehill once again established coverage of Plains All American Pipeline, L.P (NASDAQ:PAA) with an Underperform rating and $10.50 price target.

8. William Penn Bancorporation (NASDAQ:WMPN)

Price's Stake Value: $5.4 million

Percentage of Michael Price's 13F Portfolio: 0.59%

Number of Hedge Fund Holders: 5

Stock Price as of September 29: $12.19

William Penn Bancorporation (NASDAQ:WMPN) operates as a bank holding company and engages in the provision of commercial and retail financial services. The Pennsylvania-based company is ranked eighth on the list of the 10 best stocks under $15 according to Michael Price.

At the end of the second quarter of 2021, William Penn Bancorporation (NASDAQ:WMPN) holds 455,000 shares of William Penn Bancorporation (NASDAQ:WMPN), amounting to $5.4 million and representing 0.59% of the fund's total portfolio value. At the end of the second quarter of 2021, 5 hedge funds in the database of Insider Monkey held stakes worth $6.79 million in William Penn Bancorporation (NASDAQ:WMPN), up from 2 hedge funds in the previous quarter with stakes amounting to $4.9 million.

For the second quarter of 2021, William Penn Bancorporation (NASADAQ:WMPN) reported revenues generated amounting to $860,000.

7. Viemed Healthcare Inc. (NASDAQ:VMD)

Price's Stake Value: $6 million

Percentage of Michael Price's 13F Portfolio: 0.66%

Number of Hedge Fund Holders: 11

Stock Price as of September 29: $5.67

Viemed Healthcare Inc. (NASDAQ:VMD) operates as of healthcare services company, providing equipment and therapy services for the treatment of patients with various respiratory diseases. Ranked seventh on the list of the 10 best stocks under $15 according to Michael Price, Viemed Healthcare Inc. (NASDAQ:VMD) has a market capitalization of $224.99 million. MFP Investor increased its stake within the company by 521% in the second quarter of 2021.

At present, MFP Investors holds 840,476 shares worth $6 million of Viemed Healthcare Inc. (NASDAQ:VMD), representing 0.66% of the fund's total investment portfolio. At the end of the second quarter of 2021, 11 hedge funds in the database of Insider Monkey held stakes worth $40.3 million in Viemed Healthcare Inc. (NASDAQ:VMD), up from 10 hedge funds in the previous quarter with stakes amounting to $30.5 million.

On August 2, Viemed Healthcare Inc. (NASDAQ:VMD) issued its quarterly earnings report for the second quarter of 2021, with reported earnings per share at $0.04, beating market estimates by $0.01. In addition, the company generated revenues amounting to $27.4 million, surpassing estimates by $69,670.

Out of the hedge funds being tracked by Insider Monkey, California-based investment fund Cove Street Capital is a leading shareholder of Viemed Healthcare Inc. (NASDAQ:VMD), with over 1.75 million shares worth $12.5 million.

Just like Facebook, Inc. (NASDAQ:FB), Amazon.com, Inc. (NASDAQ:AMZN), Intel Corporation (NYSE:INTC) and Alphabet Inc. (NASDAQ:GOOG), Viemed Healthcare Inc. (NASDAQ:VMD) is a notable stock in Michael Price's portfolio.

In the Q2 2021 investor letter of Richie Capital Group, the fund mentioned Viemed Healthcare, Inc. (NASDAQ:VMD). Here is what the fund said:

Viemed (VMD – down 29 % in the quarter) – The respiratory healthcare services company has experienced a challenging 2021 after benefiting from the pandemic in 2020. Growth has slowed in their core business primarily from Respiratory Technicians having difficulties accessing healthcare facilities due to Covid restrictions. The company was able to offset these challenges last year by providing much needed ventilators to hospitals. Now that economies are opening up, VMD expects to regain access to hospitals and get back to their 30%+ growth. March was their busiest month for new patients since the onset of the pandemic.

The biggest impact on stock performance in the quarter came from the release of a report from the US Department of Health and Human Services, Office of the Inspector General regarding an audit of VMD’s home patients. The OIG report claimed that VMD’s charging policies did not comply with Medicare requirements and thus VMD’s patients overpaid by some $29M. The company vehemently denies these claims and issued a detailed response. I reached out to the COO to clarify the details.

The OIG findings were not aligned with the Centers for Medicare & Medicaid Services (CMS) policy which they follow and comply with. The CMS had previously conducted a detailed audit for the same period. The CMS audit reported a 98% compliance rate (41 of 42) cases, while the OIG claimed non-compliance on all 42 of the exact same cases. From VMD’s perspective, they are caught in the crossfire between two sister agencies.

VMD has received no negative feedback from their hospital clients. And for all patients, a hospital employee is involved with the sales process for every non-invasive ventilator. The company expects this to pass with limited to no monetary repercussions.”

6. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Price's Stake Value: $6.6 million

Percentage of Michael Price's 13F Portfolio: 0.73%

Number of Hedge Fund Holders: 28

Stock Price as of September 29: $13.24

Originally known as Microbia, Inc., Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) is a pharmaceutical company that develops and commercializes drugs for gastrointestinal and cardiovascular diseases. The company has a market capitalization of $2.16 billion, and is ranked sixth on the list of the 10 best stocks under $15 according to Michael Price.

According to the recent 13F Filings, Michael Price's MFP Investors holds over 520,000 shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), amounting to over $6.6 million in worth and representing 0.73% of the fund’s total portfolio. At the end of the second quarter of 2021, 28 hedge funds in the database of Insider Monkey held stakes worth $498 million in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD). The number of hedge funds that held stakes within the company remained unchanged across the first and second quarters of 2021.

For the second quarter of 2021, Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) reported earnings per share at $0.34, crossing consensus estimated by $0.12. The company also reported revenues of $104.03 million, beating forecast predictions by $11.56 million.

In July, Morgan Stanley raised its price target on Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) to $12 and kept an Equal Weight rating on the shares.

Out of the hedge funds being tracked by Insider Monkey, Connecticut-based investment fund Sarissa Capital Management is a leading shareholder of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), with over 16.3 million shares worth $210.9 million.

Click to continue reading and see 5 Best Stocks Under $15 According to Billionaire Michael Price.

Suggested articles:

Disclosure. None. 10 Best Stocks Under $15 According to Billionaire Michael Price is originally published on Insider Monkey.